Review found promising nurse-led approaches for poststroke fatigue, but study quality limited confidence

Key takeaways

• The analysis evaluated thrombolysis initiated more than 4.5 hours after last known well in imaging-selected or otherwise trial-eligible patients.
• Excellent and good functional outcomes at 90 days favored thrombolysis across the pooled evidence.
• Symptomatic intracranial hemorrhage increased, although any hemorrhage and all-cause mortality were similar between groups.
• The findings apply to selected trial populations and do not replace local eligibility, imaging, contraindication, or treatment protocols.

Nursing implications

• Activate the stroke pathway without excluding a patient solely because more than 4.5 hours have elapsed. Capture the timing and eligibility data required by the local protocol, then perform the prescribed neurologic, blood-pressure, and bleeding surveillance if thrombolysis is ordered.

Limitations & cautions

• The meta-analysis combined randomized trials and individual-patient-data meta-analyses with different agents, time windows, imaging strategies, vascular territories, and use of endovascular treatment. Selection criteria were trial-specific, and pooled findings do not define eligibility or treatment for an individual patient.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Ten publications included 1,045 patients with 1,368 acute MOGAD attacks.
• Eight studies contributed data for meta-analysis, including 710 patients and 1,033 attacks.
• Plasmapheresis was associated with visual improvement in optic neuritis and favorable recovery in other attack presentations.
• High heterogeneity, variable timing and severity, and the absence of randomized comparisons limit treatment-effect and safety conclusions.

Nursing implications

• Document the neurologic and visual baseline before treatment when feasible, follow the ordered plasmapheresis monitoring pathway, and trend the same clinical domains across exchanges. Escalate deterioration, treatment intolerance, or new symptoms promptly through the neurology and apheresis teams.

Limitations & cautions

• The evidence came from heterogeneous, nonrandomized studies with differences in attack type, severity, prior treatment, plasmapheresis timing, and outcome definitions. Recovery estimates had wide intervals, confounding by treatment selection is likely, and a low pooled adverse-effect rate cannot establish comparative safety.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The prospective validation included 472 encounters at two pediatric emergency departments, and 11.7% involved medication for agitation or physical or mechanical restraint.
• The five-item nurse-completed score showed moderate discrimination, with an area under the curve of 0.72.
• Agitation requiring intervention increased across score levels, reaching 31.8% at a score of 4 and 36.0% at 5.
• Low scores had a high negative predictive value but poor specificity, so the score is better used as one input to safety planning than as a stand-alone rule.

Nursing implications

• If the BRACHA-S is part of the local workflow, complete it alongside the full behavioral and safety assessment, communicate elevated scores during handoff, and start protocol-directed de-escalation and environmental planning early. Reassess when behavior or clinical status changes rather than relying on the arrival score alone.

Limitations & cautions

• This was an observational prognostic study at two pediatric emergency departments. The outcome combined medication and restraint use, which may reflect local practice as well as patient behavior. Discrimination was moderate, the positive predictive value for high scores remained about one third, and the abstract does not establish whether using the score improves safety or reduces restrictive interventions.
• AI-summarized from the linked source. Review the original article before applying to practice.